Robinhood
Dukascopy
VS
Higher Rated
Dukascopy
Capital at risk · T&Cs apply
Compare Robinhood and Dukascopy side by side on fees, regulation, platforms and our expert ratings. Find out which broker suits your needs.
Robinhood
Dukascopy
Dukascopy is the better choice overall, scoring 3.7/5 vs 3.6/5 on BrokerRank's independent rating. On fees, Robinhood offers lower spreads (0 pips).
See full side-by-side comparison belowOverall Rating
Dukascopy
3.6 vs 3.7
Lowest Fees
Robinhood
0 vs 0.1 pips
Regulation
Tied
2 vs 2 licences
Min. Deposit
Robinhood
$0 vs $100
Robinhood
WinnerDukascopy
Robinhood
Lower feesDukascopy
Robinhood scores 3.60/5 while Dukascopy scores 3.71/5 in our independent rating.
Dukascopy edges ahead overall, but Robinhood may suit traders who prioritise different features. Read our full reviews for a detailed breakdown. Scores are based on our transparent methodology.
Dukascopy scores higher overall on our independent rating system. Robinhood holds a 3.6/5 rating vs Dukascopy's 3.7/5. The best choice ultimately depends on your trading style — see our full verdict above for a detailed breakdown.
Robinhood offers spreads from 0 pips, while Dukascopy starts at 0.1 pips. Check the fees section above for a full breakdown.
Robinhood requires a minimum deposit of $0. Dukascopy requires $100.
Robinhood is regulated by SEC, CFTC, while Dukascopy holds licences from FCA, MAS.
Robinhood supports Proprietary Web, Proprietary Mobile. Dukascopy supports Proprietary Web, Proprietary Mobile, MT4.
Yes, you can hold accounts at multiple brokers simultaneously. Many traders diversify across platforms to access different markets and tools.
Only 26% of Brokers Are Truly Fee-Free
BrokerRank Research — Hidden costs across 345 brokers
58% of Brokers Hold a Single Licence
BrokerRank Research — Regulation quality analysis
71% of Retail Traders Lose Money
BrokerRank Research — Loss rates across 50 EU brokers
76% of Brokers Use Proprietary Platforms
BrokerRank Research — MT4 vs MT5 vs proprietary
Trading involves risk. Past performance is not indicative of future results. Capital at risk. Full risk disclosure.